Infants with acute lymphoblastic leukemia: No evidence for high methotrexate resistance

N. L. Ramakers-van Woerden; R. Pieters; M. G. Rots; C. H. van Zantwijk; P. Noordhuis; H. B. Beverloo; G. J. Peters; E. R. Van Wering; B. M. Camitta; C. H. Pui; M. V. Relling; W. E. Evans; A. J.P. Veerman

doi:10.1038/sj.leu.2402491

Infants with acute lymphoblastic leukemia: No evidence for high methotrexate resistance

N. L. Ramakers-van Woerden
, R. Pieters
, M. G. Rots
, C. H. van Zantwijk
, P. Noordhuis
, H. B. Beverloo
, G. J. Peters
, E. R. Van Wering
, B. M. Camitta
, C. H. Pui
, M. V. Relling
, W. E. Evans
, A. J.P. Veerman

Research output: Contribution to journal › Letter › peer-review

11 Citations (Scopus)

Original language	English
Pages (from-to)	949-951
Number of pages	3
Journal	Leukemia
Volume	16
Issue number	5
DOIs	https://doi.org/10.1038/sj.leu.2402491
Publication status	Published - 2002
Externally published	Yes

Access to Document

10.1038/sj.leu.2402491

Cite this

Ramakers-van Woerden, N. L., Pieters, R., Rots, M. G., van Zantwijk, C. H., Noordhuis, P., Beverloo, H. B., Peters, G. J., Van Wering, E. R., Camitta, B. M., Pui, C. H., Relling, M. V., Evans, W. E., & Veerman, A. J. P. (2002). Infants with acute lymphoblastic leukemia: No evidence for high methotrexate resistance. Leukemia, 16(5), 949-951. https://doi.org/10.1038/sj.leu.2402491

@article{392271f5c0444c0cb2131dd08571b14e,

title = "Infants with acute lymphoblastic leukemia: No evidence for high methotrexate resistance",

author = "\{Ramakers-van Woerden\}, \{N. L.\} and R. Pieters and Rots, \{M. G.\} and \{van Zantwijk\}, \{C. H.\} and P. Noordhuis and Beverloo, \{H. B.\} and Peters, \{G. J.\} and \{Van Wering\}, \{E. R.\} and Camitta, \{B. M.\} and Pui, \{C. H.\} and Relling, \{M. V.\} and Evans, \{W. E.\} and Veerman, \{A. J.P.\}",

note = "Funding Information: This work was supported in part by the Dutch Cancer Society grant VU95–921, by St Jude Cancer Center Grant CA21765, by NIH grants R37CA36401, R01CA78224, R01CA51001, by the American Lebanese Syrian Associated Charities, and by USPHS grants CA32053 and CA29139. We wish to thank the pediatric oncological centers participating in the DCLSG, COALL, BFM and POG study groups. Karyotyping of the Dutch patients was performed by members of the Netherlands Working Party on Cancer Genetics and Cytogenetics at regional cytogenetics centers and for German childhood cases karyotyping was performed in the Oncogenetic Laboratory, Children{\textquoteright}s Hospital, University of Giessen, Germany. We thank Prof W-D Ludwig and Prof OA Haas (German and Austrian BFM, respectively) for their efforts in supplying cryopreserved samples of infa nts with ALL fo r this study. We also wish to thank Dr J Shuster, POG Statistical Office, University of Florida, Gainsville FL, for providing the clinical information for the POG samples.",

year = "2002",

doi = "10.1038/sj.leu.2402491",

language = "English",

volume = "16",

pages = "949--951",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "5",

}

TY - JOUR

T1 - Infants with acute lymphoblastic leukemia

T2 - No evidence for high methotrexate resistance

AU - Ramakers-van Woerden, N. L.

AU - Pieters, R.

AU - Rots, M. G.

AU - van Zantwijk, C. H.

AU - Noordhuis, P.

AU - Beverloo, H. B.

AU - Peters, G. J.

AU - Van Wering, E. R.

AU - Camitta, B. M.

AU - Pui, C. H.

AU - Relling, M. V.

AU - Evans, W. E.

AU - Veerman, A. J.P.

N1 - Funding Information: This work was supported in part by the Dutch Cancer Society grant VU95–921, by St Jude Cancer Center Grant CA21765, by NIH grants R37CA36401, R01CA78224, R01CA51001, by the American Lebanese Syrian Associated Charities, and by USPHS grants CA32053 and CA29139. We wish to thank the pediatric oncological centers participating in the DCLSG, COALL, BFM and POG study groups. Karyotyping of the Dutch patients was performed by members of the Netherlands Working Party on Cancer Genetics and Cytogenetics at regional cytogenetics centers and for German childhood cases karyotyping was performed in the Oncogenetic Laboratory, Children’s Hospital, University of Giessen, Germany. We thank Prof W-D Ludwig and Prof OA Haas (German and Austrian BFM, respectively) for their efforts in supplying cryopreserved samples of infa nts with ALL fo r this study. We also wish to thank Dr J Shuster, POG Statistical Office, University of Florida, Gainsville FL, for providing the clinical information for the POG samples.

PY - 2002

Y1 - 2002

UR - https://www.scopus.com/pages/publications/18444409012

U2 - 10.1038/sj.leu.2402491

DO - 10.1038/sj.leu.2402491

M3 - Letter

C2 - 11986959

AN - SCOPUS:18444409012

SN - 0887-6924

VL - 16

SP - 949

EP - 951

JO - Leukemia

JF - Leukemia

IS - 5

ER -